Compare Peptides
Not sure which peptide is right for your research? Compare mechanisms of action, benefits, dosing protocols, and safety profiles side by side.
Interactive Comparison Tool
Select two peptides to compare
Choose from 41 peptides to see a detailed side-by-side analysis
Popular Comparisons
BPC-157 vs TB-500
BPC-157 excels at localized tissue repair (tendons, ligaments, GI tract) while TB-500 provides systemic healing through upregulation of actin. They are frequently stacked together for comprehensive recovery.
Semaglutide vs Tirzepatide
Tirzepatide is a dual GIP/GLP-1 agonist showing slightly greater weight loss in head-to-head trials compared to Semaglutide (a GLP-1 agonist alone). However, Semaglutide has a longer track record and more extensive safety data.
CJC-1295 vs Ipamorelin
CJC-1295 stimulates sustained growth hormone release via GHRH receptor activation, while Ipamorelin triggers pulsatile GH release through the ghrelin receptor. They are commonly stacked to mimic natural youthful GH patterns.
Semax vs Selank
Semax primarily enhances cognitive performance and BDNF expression, while Selank focuses on anxiolytic effects and stress reduction. They are often stacked for focused calm during demanding cognitive work.
Epithalon vs GHK-Cu
Epithalon targets cellular aging through telomerase activation, while GHK-Cu promotes tissue regeneration and collagen synthesis. They address aging at different biological levels and are complementary in longevity protocols.
Semaglutide vs Retatrutide
Retatrutide is a triple agonist (GLP-1/GIP/glucagon) showing potentially greater weight loss than Semaglutide in early trials. However, Semaglutide has full FDA approval and extensive real-world data while Retatrutide is still in clinical development.
Tirzepatide vs Retatrutide
Both are next-generation weight loss peptides. Tirzepatide is a dual GIP/GLP-1 agonist that is FDA-approved, while Retatrutide adds glucagon receptor agonism as a triple agonist still in trials. Retatrutide may offer greater efficacy but lacks approval.
Thymosin Alpha-1 vs LL-37
Thymosin Alpha-1 enhances adaptive immunity through T-cell maturation and modulation, while LL-37 is a cathelicidin antimicrobial peptide that provides innate immune defense. They address different arms of the immune system.
Why Compare Peptides?
Choosing the right peptide for research requires understanding the unique mechanisms, benefits, and safety profiles of each compound. Many peptides in the same category (such as weight loss or healing) work through different biological pathways, making direct comparison essential for informed decision-making. Our comparison tool helps researchers evaluate peptides based on molecular weight, mechanism of action, dosing protocols, potential benefits, and known side effects.
Some peptides, like BPC-157 and TB-500, are often compared because they serve similar recovery purposes but through different mechanisms. Others, like Semaglutide and Tirzepatide, are compared because they represent different generations of the same therapeutic approach. Use our comparisons to find the best fit for your research needs.
Ready to Start Your Research?
Browse our complete peptide database or check out our stacking guides for optimized protocols.